Praxair acquires NOxBOX
Praxair Inc. has acquired NOxBOX Ltd, a company that specializes in the manufacture of inhaled gas delivery and monitoring instruments for the medical market.
NOxBOX was previously owned by U.K.-based Bedfont Scientific Limited, an existing Praxair supplier. Financial terms of the transaction were not disclosed.
NOxBOX Ltd, which will remain headquartered in the U.K., provides a range of medical devices for in-hospital use as currently authorized by local regulation. One such device, the NOxBOXi™ delivery system, which is currently sold in many countries, provides intelligent nitric oxide delivery with precise real-time monitoring of nitric oxide, nitrogen dioxide and oxygen through a touch screen with step-by-step guided interface to enable ease of use.
“We are very pleased to have acquired this comprehensive means of delivering and monitoring nitric oxide for patients in need of inhaled nitric oxide therapy,” said Scott Telesz, executive vice president, Praxair. “The acquisition of this product line is part of our long-term strategy to further broaden our offerings to hospitals and deliver the latest in respiratory healthcare technology to our customers around the world.”